
http://www.nytimes.com/2010/09/02/healt ... er.html?hp
Moderators: Site Moderators, FAHC Science Team
I guess no one really knows why the Lilly drug failed, and are awaiting more information. Meanwhile, the attached seems like a more targeted and selective approach than what Lilly used, so perhaps that was the problem. I guess the good news is that there seem to be a number of approaches being tested, and hopefully the knowledge gained by their failures or success will help find the right approach.7im wrote:Didn't the article you posted yesterday refute the amyloid link?